Riskpilot← Back to searchSign inGet full accessTRONDHEIM ØRE-NESE-HALS AS
ASActiveOrg 922969612Erling Høviks Veg 17A, 7059 JakobsliMedical specialists activities · NACE 8622Est. 20192 employees
Revenue 2025
NOK 11M
+6% vs 2024
EBITDA margin
69.2%
+7% vs 2024
Equity ratio
1.0%
Financial strength
Net profit 2025
NOK 6M
+13% vs 2024
| Revenue | NOK 11M | +6% |
| EBITDA | NOK 7,6M | +7% |
| Net profit | NOK 6M | +13% |
| Total assets | NOK 9,5M | +8% |
| Equity | NOK 97K | -18% |
| Employees | 2 | — |
Legal name
TRONDHEIM ØRE-NESE-HALS AS
Org number
922969612
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
26. juni 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder eller daglig leder hver for seg.
Company purpose
Spesialisthelsetjeneste innen øre-nese-halssykdommer.
Address
Erling Høviks Veg 17A, 7059 Jakobsli
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 319 | 8 367 | 8 594 | 10 396 | 11 038 |
| Staff expenses | −1 850 | −2 126 | −1 864 | −2 101 | −2 185 |
| EBITDA | 5 024 | 4 757 | 4 923 | 7 144 | 7 638 |
| Depreciation & amort. | −410 | −526 | −482 | −493 | −226 |
| EBIT | 4 614 | 4 231 | 4 441 | 6 652 | 7 412 |
| Net financials | −67 | −52 | −75 | 118 | 228 |
| Profit before tax | 4 547 | 4 179 | 4 366 | 6 769 | 7 640 |
| Tax | 998 | 920 | 966 | 1 490 | 1 683 |
| Net profit | 3 549 | 3 259 | 3 399 | 5 280 | 5 957 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 056 | 6 539 | 6 544 | 8 812 | 9 496 |
| Equity | 3 573 | 89 | 88 | 118 | 97 |
| Long-term debt | 2 139 | 1 918 | 1 742 | 1 564 | 1 380 |
| Short-term debt | 1 344 | 4 532 | 4 714 | 7 129 | 8 018 |
| Total debt | 3 483 | 6 450 | 6 456 | 8 693 | 9 398 |
EBITDA margin
69.2%
This company
15.8%
Market median
+338% vs market
20212025
Equity ratio
1.0%
This company
38.2%
Market median
-97% vs market
20212025
Return on equity
6119.7%
This company
18.4%
Market median
+33159% vs market
20212025
Net profit margin
54.0%
This company
8.1%
Market median
+567% vs market
20212025
Asset turnover
1.16×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
96.55×
This company
0.62×
Market median
-15473% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ Chief Executive Officer | Chief Executive Officer | 2019 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Drabløs Holding As
TRONDHEIM ØRE-NESE-HALS AS Board members of TRONDHEIM ØRE-NESE-HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christopher Jørgen Drabløs Wiig | Chief Executive Officer | 0 companies |